Editor’s Note: This Mad in the World report features an interview with activist and attorney Ron Thompson, interviewed by Locura en Argentina founder Alan Robinson.
From serving on the boards of the American Civil Liberties Union and the Bazelon Center, and participating in advocacy initiatives supported by the National Institute of Mental Health, to collaborating with pioneering figures like Judi Chamberlin, Loren Mosher, and Thomas Szasz, Ron Thompson has been an incisive observer of the psychiatric survivor movement since 1986. Here, he speaks from a very lucid and provocative perspective about the systemic flaws of biological psychiatry, the limits of legal reform, and why guaranteeing the right to refuse treatment on irrational grounds remains the final frontier for patient autonomy.
Alan Robinson: I am Alan Robinson, and today my guest is Ron Thompson. His commitment began in 1986 after reconnecting with a former classmate detained in a psychiatric institution. Thompson has been on the frontlines of legal activism and institutional oversight, supported in part by the National Institute of Mental Health (NIMH). From 1986 to 2001, he served on the boards of the American Civil Liberties Union (ACLU) and the Bazelon Center for Mental Health Law. Throughout his life, he has engaged with key historical figures in the movement, including Judi Chamberlin, Howie the Harp, Daniel Fisher, and Thomas Szasz. Thompson offers a critique of psychiatric power, challenging traditional concepts of “patient rights” and questioning the foundational premises of biological psychiatry. Ron, welcome, and thank you for taking the time for this interview.
Ron Thompson: Thank you for the introduction, Alan. I am glad to be here.
Robinson: Let’s start from the beginning. How did you first become involved in the psychiatric patients’ rights movement in the 1980s, and how did that initial experience shape your perspective on long-term psychiatric drug use and institutional responsibility?
Thompson: My introduction in 1986 was truly a revelation. By chance, I came across an article in the Washington Post that mentioned someone I recognized from my prep school days at Phillips Exeter Academy. The article concerned St. Elizabeths Hospital in Washington, D.C.—a psychiatric facility and prison. We had been on the same wrestling team together years prior.
I decided to track him down. When I visited him at St. Elizabeths, I was astounded by his condition and the stark contrast between his life and mine. Physically, it was obvious that his incarceration and treatment had severely damaged him. He was overweight, and his skin tone was unnatural. While he held unconventional ideas—he was the son of a prominent financial figure and imagined arranging grand financial deals between China and the United States—his thoughts made a distinct kind of sense when understood within his personal history.
We formed an immediate connection. Because he could not leave on his own, I was granted permission to take him off hospital grounds for meals at a nearby Chinese restaurant. Spending time with him made me realize how extraordinarily fortunate I had been 20 years earlier during my own encounter with the psychiatric system. When I was hospitalized decades prior. I was hospitalized as a voluntary patient, a status retained throughout my connection to the McLean Hospital near Boston, Mass in the town of Belmont.
Robinson: Could you share some details regarding the reasons for your hospitalization, and how long you remained admitted? Have you been hospitalized on any other occasions?
Thompson: Many years have passed, but the treatment must have lasted approximately two and a half years. I entered the hospital in November, 1964 after a few weeks into my first semester at Georgetown University Law Center in Washington DC, when I woke up one morning and, according to memory, couldn’t see myself in the mirror. I called my parents and abruptly returned to their home in Dover, New Hampshire.
After what may have been only a few weeks, I told the doctors I was feeling sicker. Most remarkable of all their decisions, they decided that this was because of the drugs I was on, either Haldol or Thorazine, or both of them. And 3 or 4 months later, I told the doctors that I had to leave in-patient status or “something bad would happen,” whatever I meant by that. Again, the doctors made a remarkable decision, and said “ok,” despite that somewhat ominous phrase.
To summarize my treatment, it might be enough to say that my sickness was primarily due to a mother, who was not abusive in any ordinary way, but whose lifelong anxiety, combined with erratic and sudden emotional changes, and perhaps also with the example or ‘lesson’ of a father who lived with this difficult woman by more or less pretending no problem existed, led me to conclude that radical suppression of emotion was the way to deal with any and all kinds of emotional discomfort.
Robinson: For 15 years, you participated in conferences and meetings funded by a division of the NIMH to monitor and engage with the ex-patient movement. What was your role there, and looking back, how do you evaluate the relationship between government agencies and grassroots activist groups during that era?
Thompson: It has now been 40 years since I began this work in 1986. My connection with NIMH began shortly after I got involved in advocacy. At the time, Joe Rogers—a prominent and dynamic figure in the movement—had visited me after I wrote a somewhat satirical piece about his style. Despite the critique, he engaged with me respectfully, and through those networks, I was introduced to a small, progressive unit within NIMH.
This unit was experimentation-oriented. They were boldly attempting to fund patient advocates and former patients to participate in national dialogues. NIMH began sponsoring my travel to conferences across the United States and even internationally, including a conference in Finland.
This support allowed me to engage with almost every major figure in the movement. I established a close dialogue with Thomas Szasz, worked alongside Peter Breggin, and co-led a workshop with Loren Mosher, the founder of Soteria House. The leadership at NIMH’s advocacy unit was genuinely supportive. However, the relationship between government funding and radical activism is inherently complex. While federal sponsorship provided essential resources and a platform, grassroots movements always face the risk of co-optation when working within state-funded structures.
Robinson: You mentioned working with Loren Mosher. What were your discussions with the founder of Soteria House like, and how did the movement’s terminology evolve during that period?
Thompson: Loren Mosher and I shared a fundamental agreement: the dominant psychiatric paradigm was deeply broken. Soteria House proved that compassionate, non-coercive community support without heavy reliance on neuroleptics could yield superior long-term outcomes.

Regarding terminology, language was constantly debated—whether to use “ex-patients,” “psychiatric survivors,” or “consumers.” But my legal background led me to focus on a deeper conceptual issue beyond terminology. Although I graduated from law school and passed the bar, I chose not to enter traditional fee-for-service practice, retaining instead the analytical mindset of an attorney.
I have always been skeptical of how “patient rights” are framed. In standard medicine, every competent human being possesses the legally protected right to make what society might consider an “irrational refusal” of medical treatment in other people’s eyes. For instance, Steve Jobs famously delayed surgical treatment for his cancer in favor of alternative therapies. Similarly, former Oregon Senator Wayne Morse refused life-sustaining dialysis. Society may view such decisions as unwise, but the law respects personal bodily autonomy.
In psychiatry, however, this fundamental right does not exist. The moment a person’s decision is deemed “irrational” due to supposed mental illness, their right to refuse treatment is stripped away. Therefore, campaigning for minor “patient rights”—like better hospital food or phone access—without securing the fundamental right to refuse treatment remains inherently incomplete.
Robinson: That distinction is crucial. Could you elaborate further on what you mean by the “right to unreasonably refuse treatment” and how society misinterprets involuntary interventions?
Thompson: When I speak of an “unreasonable refusal” I mean a refusal that appears irrational in other people’s eyes, like observers or clinicians. To illustrate this, I wrote an essay titled A Tale of Two Patients.
It details the story of a close friend whose authoritarian parents had him involuntarily committed and subjected to physical restraints and forced drugging, despite him not being mentally ill. I supported his legal fight, and eventually, the hospital conceded and released him. Although he was vindicated, the physical trauma, dental neglect, and severe insomnia resulting from his institutionalization permanently hindered his ability to reintegrate into society. I have remained in contact with him weekly for over 30 years; he remains sane, yet severely disabled by the system that claimed to treat him.
This highlights what I call the “zero-sum fallacy” in psychiatry. Society operates under the assumption that if Person A is exhibiting unusual or disturbing behavior, then Person B (the psychiatrist) automatically knows what is best to do. The first premise may be true—someone may indeed be in distress—but the second premise is false.
If an individual poses an imminent physical threat to themselves or others, society may choose to intervene for public safety. However, that intervention must be recognized for what it is: a state security measure, not a medical treatment. Labeling involuntary confinement and forced drugging as “medical care” degrades the true meaning of medicine.
Robinson: Framing forced intervention as a security issue rather than a healthcare service clarifies the ethics involved. How did you present this distinction during your debates within psychiatric institutions?
Thompson: In the early 1990s, a colleague and I organized a debate at St. Elizabeths Hospital. During that presentation, I proposed an alternative model for psychiatric wards.
I argued that if society deems it necessary to confine an individual for safety reasons, institutional staff should be entirely honest with that person. They should say: “We do not have a medical cure for your distress, but society has mandated that you cannot leave right now. Given this reality, how can we work together as fellow human beings to make your stay tolerable and help you regain your independence?”
This approach respects the individual’s humanity. It eliminates the deception of pretending that forced drugging is a therapeutic gift. Honesty creates a foundation for genuine dialogue, whereas forced medicalization creates hostility and trauma.
Robinson: Your ideas contain legal terminology regarding the defense of psychiatric patients’ rights; did you train as a lawyer? How did you come to incorporate this highly specialized language over the course of so many years?
Thompson: In 1971, I decided to return to law school; by then I was already married to my first wife. I had a vague sense that ‘something’ wasn’t quite right with my emotional make-up, a feeling that came to the surface of my consciousness in the spring of 1974, when I had the unsettling experience of being unable to complete my final law school exams. It wasn’t because I didn’t know the answers, but because passing meant I would have to go out and find a job working for other people, and my subconscious flatly refused to allow it.
In any case, a very wise friend who was a professor told me that I ‘of course’ ought to go back and finish that final semester, which I did; I graduated and then sat and passed the bar exam.
But I realized I was incapable of wanting to work for someone else, which, over time, I came to understand was due to my inability to access the emotion of anger. This may sound strange, but in a way, accessing this emotion also means accessing the emotions necessary for self-assertion when you are in a subordinate position. It’s hard to explain.
Robinson: You have stated that despite the tireless work of activists like Judi Chamberlin and Dan Fisher, the survivor movement ultimately struggled to convince the broader public of what is fundamentally flawed in psychiatry. Why do you think the movement’s messaging faced such resistance in the 1980s and 1990s?
Thompson: Well, it’s a problem that’s continuing, and I have to say it’s also society’s problem. I don’t want to put it all on the ex-patients. The challenge lies both in strategic miscalculations within advocacy movements and in society’s deep desire for simple answers.
A clear example occurred in 1993 during the national debate over health insurance parity. There was a major legislative push to mandate equal insurance coverage for physical and mental health conditions. I argued at the time that survivor organizations should only support parity if it was strictly limited to voluntary psychiatric care.
However, many mainstream advocacy groups decided to compromise. They believed that achieving broad parity first was paramount, assuming they could address the problem of involuntary coercion later. By securing insurance parity without excluding coercive practices, the movement inadvertently legitimized involuntary psychiatry. Insurance companies were now obligated to fund forced hospitalizations and chemical restraints. Compromising on core principles weakened the movement’s moral clarity, leaving the general public unaware of the fundamental distinction between consensual care and psychiatric coercion.
Robinson: Around that time, landmark court decisions like Eleanor Riese v. St. Mary’s Hospital and Washington v. Harper addressed forced treatment. What was the impact of these legal battles, and why did litigation prove insufficient to overturn psychiatric power?
Thompson: While these cases established important procedural hurdles, they did not dismantle the underlying structure of involuntary psychiatry. Courts created procedural checks, but they ultimately left authority in the hands of administrative bodies and medical professionals.
The legal system lacks a specific civil tort tailored to remedy psychiatric abuse. Standard tort law—such as battery or medical malpractice—is routinely bypassed when courts grant broad immunity to psychiatrists acting under state civil commitment statutes. Litigation can chip away at extreme abuses, such as solitary confinement, but legal reform alone cannot dismantle a paradigm that society relies upon to manage social distress.
Robinson: What is your core critique of biological psychiatry, and why has the “brain disease” model remained so dominant despite its lack of diagnostic validity?

Thompson: Biological psychiatry claims that complex emotional suffering and behavioral distress are simply “brain diseases” or “chemical imbalances.” This concept is scientifically unproven, yet it remains enormously seductive for several reasons.
First, it appeals to psychiatrists. For decades, psychoanalysts and talking therapists faced skepticism from mainstream medicine. By rebranding emotional suffering as a biological disease, psychiatrists could claim status as “real physicians” prescribing biological cures.
Second, it appeals to patients and families looking for relief. Accepting a biological diagnosis removes personal responsibility and guilt. It offers a quick fix: take a pill to manage symptoms.
However, symptom management is not recovery. When I was hospitalized, my doctor told me something psychiatrists rarely say today: “You are going to be better than well.” They meant I could understand the root causes of my breakdown, grow through the experience, and emerge stronger than before. Modern biological psychiatry has abandoned the pursuit of genuine healing in favor of lifelong pharmaceutical management.
Robinson: Looking back at your own life, what specific factors helped you recover and live fully without psychiatric drugs?
Thompson: My recovery was made possible by a combination of empathetic clinical care, meaningful human relationships, supportive family, and personal reflection.
First, my psychoanalysts treated me with profound respect. They listened when I reported that medication was making me sicker, discontinued the drugs, and allowed me to retain my dignity. Though I was in a locked ward, I wore a coat and tie and was permitted to leave the hospital grounds.
Second, solidarity with fellow patients was crucial. I formed deep friendships with two older patients—a traumatized Vietnam veteran dealing with severe anxiety, and a man from New York suffering from deep depression. The three of us spent hours talking and supporting one another. That peer connection provided comfort that no medication could offer.
Third, my father provided unwavering support. For nearly two years following my breakdown, he enabled me to commute 75 miles round-trip three times a week for outpatient psychoanalysis.
Fourth, the clinical team demonstrated extraordinary trust. During my recovery, my mother—acting out of intense anxiety—found a small souvenir starter pistol I had purchased years earlier during a road trip and frantically called the hospital, claiming I was dangerous. When I met with the doctors, I calmly explained the situation. Instead of panicking or re-institutionalizing me, they believed me. That vote of confidence was transformative.
Finally, intellectual study guided my healing. I immersed myself in the works of psychoanalyst Harry Stack Sullivan, who distinguished between objective fear and rootless anxiety often absorbed from an anxious environment. I read Karen Horney, particularly her masterpiece Neurosis and Human Growth, which provided a roadmap for understanding self-realization. I also studied Abraham Maslow, who shifted psychology’s focus away from pathology toward studying self-actualized, psychologically healthy individuals. These thinkers provided the conceptual tools I needed to rebuild my life.
Robinson: What guidance would you offer to younger generations of activists who are advocating for patient autonomy, human rights, and the psychiatric survivor movement today?
Thompson: I would encourage young advocates to cultivate deep introspection and distinguish between two fundamentally different ways of being: possessing a strong sense of self versus possessing a strong ego.
A strong sense of self is grounded in internal values, self-awareness, reason, and empathy. Consider Abraham Lincoln. He possessed an extraordinary sense of self—he was reflective, capable of deep empathy, and guided by principle. In contrast, a strong ego is fragile, defensive, and pathologically self-centered, demanding constant validation while lacking empathy.
Effective advocacy requires emotional maturity. Activists must learn to distinguish between genuine, constructive emotions and neurotic, reactive drives. They must also seek out wise mentors. Peer support is vital, but learning from older generations who have navigated these struggles provides invaluable perspective.
In my own youth, my role model was my YMCA camp director, Oscar Elwell. He embodied calm authority without a trace of authoritarianism. He inspired discipline, integrity, and respect across generations.
To transform psychiatry, activists must embody those same principles: combine fierce dedication to human rights with rigorous intellectual clarity, personal integrity, and genuine empathy. We must continue to demand a system that honors human dignity, respects bodily autonomy, and recognizes the inherent capacity of every individual to heal.
Robinson: Are you currently involved in any support groups for survivors or in any type of advocacy work? If not, when did you stop that activity, and what do you do now?
Thompson: After that first, very active period between 1986 and 2001, I never completely left the movement. The last 25 years have been characterized by a constant focus on psychiatric issues and ongoing contact with various people, including activists.
I also recently got in touch with a psychologist and a TAO (Threat Assessment Officer), and now this connection suggests a possible political initiative that could be more promising than anything I have been involved in since, sadly, the initial promise of the advocacy movement began to fade at the turn of the century.

One of the reasons for my reduced activity—if not my diminished attention and interest—has been my view that the advocacy community, whilst never lacking in integrity or commitment, has, in my opinion, never developed the best political strategies.
On a more personal level, when I am not dealing with or thinking about issues relating to the defense of psychiatric rights, I spend a great deal of time reading and reflecting on current and past history, about which I have written. And ever since my wife and I realized we shared a passion for travel, we have taken countless trips over the last 40 years, which have taken us, quite literally, all over the world.
Robinson: Ron, thank you for sharing your journey, your legal insights, and your knowledge with us today.
Thompson: It has been my pleasure, Alan. Thank you.